APGE vs MRVL · $2.34B cap vs P/E 100, rev $5.16B
Apogee Therapeutics, Inc. Common Stock (APGE) versus Marvell Technology Group Ltd (MRVL) — a side-by-side from cached financials, not a winner call.
Apogee Therapeutics, Inc. Common Stock (APGE) is a biotechnology company listed on US.
Marvell Technology Group Ltd (MRVL) is a semiconductors company listed on NASDAQ. It is led by Matthew J. Murphy.
APGE does not have a complete income-statement cache yet.
Latest reported MRVL revenue for 2026-08-01 was $5.16B. Net income was $342.5M. MRVL currently screens at market cap $253.51B and trailing P/E 99.8.
APGE currently screens at market cap $2.34B. MRVL currently screens at market cap $253.51B and trailing P/E 99.8.
Not investment advice. Open the APGE and MRVL stock pages for the full models.
Not investment advice.